Journal of the American Geriatrics Society
Fecha de publicación: 11 September 2019
DOI: https://doi.org/10.1111/jgs.16157
Autores: Parag Goyal MD, MSc., Timothy S. Anderson MD, MAS, MA., Gwen M. Bernacki MD, MHSA., Zachary A. Marcum PharmD, PhD., Ariela R. Orkaby MD, MPH., Dae Kim MD, MPH, ScD., Andrew Zullo PharmD, PhD., et al.
Background: Guideline‐based management of cardiovascular disease often involves prescribing multiple medications, which contributes to polypharmacy and risk for adverse drug events in older adults. Deprescribing is a potential strategy to mitigate these risks. We sought to characterize and compare clinician perspectives regarding deprescribing cardiovascular medications across three specialties.
